Connected Medical Devices
This white paper, “Connected Medical Devices”, explores the transformative impact of integrating Bluetooth Low Energy (BLE), mobile apps, cloud platforms, and AI/ML into medical devices. It highlights the benefits of…
Life Sciences Strategy and Innovation
This white paper explores the evolution of current biopharmaceutical commercial models. By addressing key considerations essential for every healthcare leader, this shares the impact of integrating digital assets clinician engagement…
Transforming Digital Innovation to Business Reality in Life Sciences
The industry is at the forefront of physical and digital technologies, with implications for research, development, manufacturing and patient care. Digital technologies and workflows can unlock discoveries, leading to new…
Third-Party Hardware Modification of Interventional X-Ray Equipment
This technical white paper outlines concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers.
The Global Democratization of Point-of-Care & At-Home Diagnostic Testing
One of healthcare’s most extensive and rapidly expanding market segments, Pointof-Care (POC) and at-home rapid diagnostic testing, has become an ever-increasing crucial topic in the medical world since COVID-19 was…
The Role of Artificial Intelligence (AI) in Healthcare
Artificial intelligence (AI) applied to healthcare, driven by innovative medical technology, has and will continue to transform patient care. These advancements can enable clinicians to better understand diseases, achieve faster…
AdvaMed Medical Imaging™ Standards
AdvaMed® creates industry standards and white papers relevant to medical imaging technology, including X-Ray, CT, Ultrasound, MR, and molecular imaging modalities.
Racial and Ethnic Diversity in FDA Regulated Clinical Trials
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Phase III: Disparities in Access to Selected Advanced Medical Procedures in the Medicare Population
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.